132 related articles for article (PubMed ID: 38072238)
21. A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease.
Greig JA; Nordin JML; Smith MK; Ashley SN; Draper C; Zhu Y; Bell P; Buza EL; Wilson JM
Hum Gene Ther Clin Dev; 2019 Mar; 30(1):29-39. PubMed ID: 30693797
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte GP73 expression in Wilson disease.
Wright LM; Huster D; Lutsenko S; Wrba F; Ferenci P; Fimmel CJ
J Hepatol; 2009 Sep; 51(3):557-64. PubMed ID: 19596473
[TBL] [Abstract][Full Text] [Related]
23. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
24. Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.
Chen K; Wu L; Liu Q; Tan F; Wang L; Zhao D; Fang X; Liu X; Liu J; Han H
Biomed Pharmacother; 2023 Feb; 158():114107. PubMed ID: 36502753
[TBL] [Abstract][Full Text] [Related]
25. Update on the Diagnosis and Management of Wilson Disease.
Roberts EA
Curr Gastroenterol Rep; 2018 Nov; 20(12):56. PubMed ID: 30397835
[TBL] [Abstract][Full Text] [Related]
26. Early-life stress and dietary fatty acids impact the brain lipid/oxylipin profile into adulthood, basally and in response to LPS.
Reemst K; Broos JY; Abbink MR; Cimetti C; Giera M; Kooij G; Korosi A
Front Immunol; 2022; 13():967437. PubMed ID: 36131915
[TBL] [Abstract][Full Text] [Related]
27. Defective localization of the Wilson disease protein (ATP7B) in the mammary gland of the toxic milk mouse and the effects of copper supplementation.
Michalczyk AA; Rieger J; Allen KJ; Mercer JF; Ackland ML
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):565-71. PubMed ID: 11085952
[TBL] [Abstract][Full Text] [Related]
28. Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
Garcia-Jaramillo M; Spooner MH; Löhr CV; Wong CP; Zhang W; Jump DB
PLoS One; 2019; 14(4):e0214387. PubMed ID: 30943218
[TBL] [Abstract][Full Text] [Related]
29. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.
Depner CM; Traber MG; Bobe G; Kensicki E; Bohren KM; Milne G; Jump DB
PLoS One; 2013; 8(12):e83756. PubMed ID: 24358308
[TBL] [Abstract][Full Text] [Related]
30. Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) mice.
Hamilton JP; Koganti L; Muchenditsi A; Pendyala VS; Huso D; Hankin J; Murphy RC; Huster D; Merle U; Mangels C; Yang N; Potter JJ; Mezey E; Lutsenko S
Hepatology; 2016 Jun; 63(6):1828-41. PubMed ID: 26679751
[TBL] [Abstract][Full Text] [Related]
31. Time course of western diet (WD) induced nonalcoholic steatohepatitis (NASH) in female and male Ldlr-/- mice.
Spooner MH; Garcia-Jaramillo M; Apperson KD; Löhr CV; Jump DB
PLoS One; 2023; 18(10):e0292432. PubMed ID: 37819925
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography of copper metabolism in the Atp7b-/- knock-out mouse model of Wilson's disease.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Feb; 14(1):70-8. PubMed ID: 21327972
[TBL] [Abstract][Full Text] [Related]
33. Modifying factors and phenotypic diversity in Wilson's disease.
Lutsenko S
Ann N Y Acad Sci; 2014 May; 1315():56-63. PubMed ID: 24702697
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive and comparative exploration of the Atp7b
Lacombe M; Jaquinod M; Belmudes L; Couté Y; Ramus C; Combes F; Burger T; Mintz E; Barthelon J; Leroy V; Poujois A; Lachaux A; Woimant F; Brun V
Metallomics; 2020 Feb; 12(2):249-258. PubMed ID: 31815268
[TBL] [Abstract][Full Text] [Related]
35. Lipidomic profiling of targeted oxylipins with ultra-performance liquid chromatography-tandem mass spectrometry.
Yuan ZX; Majchrzak-Hong S; Keyes GS; Iadarola MJ; Mannes AJ; Ramsden CE
Anal Bioanal Chem; 2018 Sep; 410(23):6009-6029. PubMed ID: 30074088
[TBL] [Abstract][Full Text] [Related]
36. Early stage transplantation of bone marrow cells markedly ameliorates copper metabolism and restores liver function in a mouse model of Wilson disease.
Chen X; Xing S; Feng Y; Chen S; Pei Z; Wang C; Liang X
BMC Gastroenterol; 2011 Jun; 11():75. PubMed ID: 21676234
[TBL] [Abstract][Full Text] [Related]
37. Restoration of copper metabolism and rescue of hepatic abnormalities in LEC rats, an animal model of Wilson disease, by expression of human ATP7B gene.
Meng Y; Miyoshi I; Hirabayashi M; Su M; Mototani Y; Okamura T; Terada K; Ueda M; Enomoto K; Sugiyama T; Kasai N
Biochim Biophys Acta; 2004 Nov; 1690(3):208-19. PubMed ID: 15511628
[TBL] [Abstract][Full Text] [Related]
38. Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.
Sarode GV; Kim K; Kieffer DA; Shibata NM; Litwin T; Czlonkowska A; Medici V
Metabolomics; 2019 Mar; 15(3):43. PubMed ID: 30868361
[TBL] [Abstract][Full Text] [Related]
39. A novel gross deletion and breakpoint junction sequence analysis of ATP7B in a Chinese family with Wilson disease using next‑generation sequencing and Sanger sequencing.
Liu WL; Li F; Liu L; Chen W; He ZX; Gu H; Ai R
Mol Med Rep; 2020 Jan; 21(1):517-523. PubMed ID: 31746411
[TBL] [Abstract][Full Text] [Related]
40. Age-dependent changes of cerebral copper metabolism in Atp7b
Xie F; Xi Y; Pascual JM; Muzik O; Peng F
Metab Brain Dis; 2017 Jun; 32(3):717-726. PubMed ID: 28130615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
